PIXACOP 5

PIXACOP 5

Composition Apixaban 5mg
Dosage TABLET
Packing Size 10x1x10
Packing Blister

Professional Care, Consistent Results

At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.

Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.

With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.

Additional information

PIXACOP 5 — Apixaban 5 mg Tablets

Overview

PIXACOP 5 contains Apixaban 5 mg, a direct oral anticoagulant (DOAC) used to prevent and treat blood clots. It works by inhibiting Factor Xa, a key protein in the blood clotting process, helping reduce the risk of stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE).

PIXACOP 5 is ideal for patients who require effective anticoagulation therapy without the need for routine blood monitoring, offering convenient once- or twice-daily dosing.


Composition

Each tablet contains:

  • Apixaban 5 mg – Direct Factor Xa inhibitor that prevents clot formation in the blood.

(Excipients q.s., as per approved formulation.)


Dosage Form

  • Tablet


Therapeutic Class

  • Anticoagulant / Factor Xa Inhibitor


Indications

PIXACOP 5 Tablets are indicated for:

  • Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation

  • Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE)

  • Reduction of recurrent DVT and PE risk

  • Patients requiring anticoagulation without regular INR monitoring


Mechanism of Action

  • Apixaban selectively inhibits Factor Xa, which is essential for the conversion of prothrombin to thrombin.

  • By blocking this pathway, it prevents thrombin formation and clot development.

  • This helps maintain normal blood flow and reduces the risk of stroke, DVT, and PE.


Dosage and Administration

  • Recommended Dose: As prescribed by the physician, typically 5 mg twice daily for most indications

  • Route: Oral

  • Duration: As advised by the healthcare provider depending on the condition

Note: Do not stop the medication without consulting your doctor. Missed doses should be taken as soon as possible unless it’s near the next scheduled dose.


Benefits

  • Prevents stroke and systemic embolism in atrial fibrillation patients

  • Treats and prevents DVT and PE

  • Reduces the risk of recurring blood clots

  • Does not require routine blood monitoring like warfarin

  • Convenient oral administration


Side Effects

PIXACOP 5 is generally well tolerated. Possible side effects include:

  • Bleeding (nosebleeds, gum bleeding, or easy bruising)

  • Anemia or fatigue

  • Nausea or stomach upset

  • Rarely, serious bleeding events

Patients should seek immediate medical attention if severe bleeding occurs.


Precautions

  • Avoid use in patients with active bleeding or high bleeding risk

  • Use with caution in liver or kidney impairment

  • Inform your doctor about other medications, especially anticoagulants or antiplatelets

  • Not recommended during pregnancy or lactation unless prescribed

  • Regular clinical monitoring may be advised in high-risk patients


Storage

Store below 25°C, in a dry place away from sunlight. Keep out of reach of children.


Key Product Information

  • Brand Name: PIXACOP 5

  • Composition: Apixaban 5 mg

  • Dosage Form: Tablet

  • Therapeutic Class: Anticoagulant / Factor Xa Inhibitor

  • Manufacturer: [Insert Company Name]

  • Packaging: [Example: 10×10 Tablets / Strip]


Why Choose PIXACOP 5

  • Provides effective anticoagulation therapy

  • Reduces stroke, DVT, and PE risk

  • Convenient oral dosing without routine INR monitoring

  • Manufactured under strict GMP-certified quality standards


Conclusion

PIXACOP 5 (Apixaban 5 mg Tablets) delivers safe and effective anticoagulation for patients at risk of stroke, DVT, and PE. By selectively inhibiting Factor Xa, it helps prevent clot formation, supporting long-term cardiovascular and vascular health.